NYSE - Delayed Quote USD

HCA Healthcare, Inc. (HCA)

Compare
395.83 +0.24 (+0.06%)
At close: September 3 at 4:00 PM EDT
395.61 -0.22 (-0.06%)
Pre-Market: 7:15 AM EDT
Loading Chart for HCA
DELL
  • Previous Close 395.59
  • Open 396.00
  • Bid --
  • Ask 633.32 x 900
  • Day's Range 393.93 - 397.61
  • 52 Week Range 215.96 - 397.73
  • Volume 919,618
  • Avg. Volume 1,191,879
  • Market Cap (intraday) 102.153B
  • Beta (5Y Monthly) 1.68
  • PE Ratio (TTM) 18.58
  • EPS (TTM) 21.30
  • Earnings Date Oct 22, 2024 - Oct 28, 2024
  • Forward Dividend & Yield 2.64 (0.67%)
  • Ex-Dividend Date Sep 16, 2024
  • 1y Target Est 399.24

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

www.hcahealthcare.com

220,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HCA

View More

Performance Overview: HCA

Trailing total returns as of 9/3/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

HCA
46.82%
S&P 500
15.91%

1-Year Return

HCA
42.17%
S&P 500
22.44%

3-Year Return

HCA
60.59%
S&P 500
21.86%

5-Year Return

HCA
242.90%
S&P 500
88.93%

Compare To: HCA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HCA

View More

Valuation Measures

Annual
As of 9/3/2024
  • Market Cap

    102.15B

  • Enterprise Value

    144.10B

  • Trailing P/E

    18.58

  • Forward P/E

    15.77

  • PEG Ratio (5yr expected)

    1.19

  • Price/Sales (ttm)

    1.56

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    2.11

  • Enterprise Value/EBITDA

    10.58

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.40%

  • Return on Assets (ttm)

    11.47%

  • Return on Equity (ttm)

    736.11%

  • Revenue (ttm)

    68.35B

  • Net Income Avi to Common (ttm)

    5.74B

  • Diluted EPS (ttm)

    21.30

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    918M

  • Total Debt/Equity (mrq)

    3,194.47%

  • Levered Free Cash Flow (ttm)

    3.2B

Research Analysis: HCA

View More

Company Insights: HCA

Research Reports: HCA

View More

People Also Watch